Genoptix a Novartis Company Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Genoptix a Novartis Company's estimated annual revenue is currently $61.2M per year.(i)
  • Genoptix a Novartis Company's estimated revenue per employee is $297,000

Employee Data

  • Genoptix a Novartis Company has 206 Employees.(i)
  • Genoptix a Novartis Company grew their employee count by -6% last year.

Genoptix a Novartis Company's People

NameTitleEmail/Phone
1
Chief Legal Officer and General CounselFletcherReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
EVP & COOReveal Email/Phone
4
Associate Director, CytogeneticsReveal Email/Phone
5
Manager, GxP Quality SystemsReveal Email/Phone
6
Validation Project ManagerReveal Email/Phone
7
Histology ManagerReveal Email/Phone
8
Marketing Coordinator and Conference ManagerReveal Email/Phone
9
Cytogenetics ManagerReveal Email/Phone
10
Project Data CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M29146%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M415%N/AN/A
#10
$4.3M23-15%N/AN/A
Add Company

What Is Genoptix a Novartis Company?

Genoptix is one of the largest hematopathology centers in the U.S. and is a leading clinical oncology laboratory specializing in hematology and solid tumors. Located in Carlsbad, California, with a staff of over 400, and occupying over 27,000 square feet of laboratory space, Genoptix’s modern facilities are well-suited to handle the large volume of samples that enters its doors each day.

keywords:N/A

N/A

Total Funding

206

Number of Employees

$61.2M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genoptix a Novartis Company News

2017-03-07 - Ampersand Capital Partners and 1315 Capital to Acquire Genoptix from Novartis

The management team led by Joseph M. Limber, in partnership with Ampersand Capital Partners and 1315 Capital, has completed the acquisition of Genoptix, Inc., a Carlsbad, California-based provider of testing solutions in hematology and solid tumor molecular profiling, from Novartis. The financi ...

2007-10-30 - Life sciences briefing: Tuesday, Oct. 30, 2007

Featured companies: Acceleron Pharma, Bledsoe Brace Systems, Eurobiobiz, Genoptix, Harmony Information Systems, ImmuneWorks, Pasteuria Bioscience, Renal CarePartners, Quantum Genomics, Synergy Software, Vitreo Retinal Technology UPDATED: Expanded items on Genoptix and Acceleron Pharma. Diagnos ...

2007-08-01 - Genoptix files $86M IPO for diagnostic services

Genoptix, a Carlsbad, Calif., provider of diagnostic services to cancer and blood-disease specialists, filed to raise as much as $86.25 million in an intial offering. The company specializes in genetic and other testing of blood and bone-marrow samples in order to diagnose various cancers and to ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$60.1M20729%$3M
#2
$52.2M209N/AN/A
#3
$42.4M2111%N/A
#4
$54.5M2170%N/A
#5
$79.1M2181%N/A